Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, March 28, 2024 | Back issues
Courthouse News Service Courthouse News Service

Maker Of Generic Prilosec Wins Patent Ruling

WASHINGTON (CN) - Mylan Inc.'s generic version of the heartburn medication Prilosec does not infringe on AstraZeneca's patents, the Federal Circuit ruled.

The appellate court affirmed a judgment by U.S. District Judge Barbara Jones of New York, who found that the generic omeprazole - the active ingredient in Prilosec - did not infringe on AstraZeneca's patents for "oral pharmaceutical preparations for omeprazole."

AstraZeneca failed to prove that the generic drugs contain significant amounts of carbonates, the alkaline reacting compound in Prilosec.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...